19.05.2023 09:21:40
|
Major shareholder announcement
Company announcement
No. 10/2023
Orphazyme A/S
Ole Maaløes Vej 3
DK-2200 Copenhagen N
www.orphazyme.com
Company Registration No. 32266355
Copenhagen, Denmark, May 19, 2023 – Orphazyme A/S (ORPHA.CO) (the "Company”), hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from Scandinavian Investment Group A/S, that as of May 16, 2023, Scandinavian Investment Group A/S holds shares corresponding to 10.00% of the total share capital and voting rights in the Company.
For additional information, please contact
Orphazyme A/S
Michael Hove, Chairman of the board +45 28 12 66 09
Attachment
![](https://ml-eu.globenewswire.com/media/YmFkNTlhYWYtOGI0OS00YTdlLTk5NjktYWU3ODZmNzU4NzU3LTExMDI3NjI=/tiny/ORPHAZYME-A-S.png)
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Orphazyme A-S Bearer and-or registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |